Clinical Trial Update: Single Dose Recombinant Human Follicle Stimulating Hormone Fc Husion Protein (KN015) in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update assessing a single-dose KN015, a recombinant human FSH-Fc fusion protein, in healthy female volunteers to evaluate safety and ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• KN015 (recombinant human follicle-stimulating hormone Fc fusion protein)

Snippet

Sponsor: Alphamab Jilin Co., Ltd. | Conditions: Infertility, Female | Phase 1 | Status: UNKNOWN